Oramed Pharmaceuticals Inc (ORMP) Price Targets From Analysts
Use the tables below to see what analysts covering Oramed Pharmaceuticals Inc think about its future price and what recommendations they have for investors and traders.
|Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Current Price||Upside Potential|
ORMP Broker Recommendations Summary
|Average Broker Rating||Strong Buy||Buy||Hold||Sell||Strong Sell||Analysts Issuing Recs|
Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.
- The percent of analysts bearish on the stock of ORMP is less than almost 100% of all US stocks.
- The variance in analysts' estimates of ORMP is lower than 2.91% of stocks in the micro market cap category.
- The upside potential (average analyst target price relative to current price) of ORMP is greater than 92.5% of all US stocks.
- ORMP has a higher percentage of analysts bullish on the stock than 84.03% of all US stocks.
- ORMP has a higher number of analysts covering the stock than 22.88% of Pharmaceutical Products stocks.
- The average analyst price target of ORMP is higher than 23.06% of all US stocks.
- Oramed Pharmaceuticals Inc's change in bullishness amongst analysts is lower than almost 100% of all US stocks.
In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to Oramed Pharmaceuticals Inc are BLRX, MNPR and GALT.
What is the outlook for ORMP? Use POWR Ratings for clearer insight into price direction.